Big Move For Apellis Pharmaceuticals, Inc.
Tue, Mar 31, 2026 at 07:26 PM
Apellis Pharmaceuticals, Inc. (APLS:NASDAQ) rocketted at $40.23, a gain of 135.4%. On Tue, Mar 31, 2026, APLS:NASDAQ hit a New 2-Week High of $40.23. The stock got featured on our News Catalysts scanner on Tue, Mar 31, 2026 at 06:46 PM in the 'BIOTECH' category. From Tue, Mar 17, 2026, the stock recorded 50.00% Up Days and 36.36% Green Days
About Apellis Pharmaceuticals, Inc. (APLS:NASDAQ)
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.
Top 10 Gainers:
- Apellis Pharmaceuticals, Inc. (APLS:NASDAQ), 135.4%
- U-BX Technology Ltd. (UBXG:NASDAQ), 114.1%
- 3 E Network Technology Group Limited (MASK:NASDAQ), 83.06%
- PMGC Holdings Inc. (ELAB:NASDAQ), 68.26%
- Bullfrog AI Holdings, Inc. (BFRG:NASDAQ), 60%
- Jaguar Uranium Corp. Class A (JAGU:NYSEMKT), 57.14%
- Texxon Holding Limited (NPT:NASDAQ), 56.81%
- Classover Holdings, Inc. (KIDZ:NASDAQ), 50.24%
- Globavend Holdings Limited (GVH:NASDAQ), 46.71%
- WeShop Holdings Limited (WSHP:NASDAQ), 46.27%